218 related articles for article (PubMed ID: 24785509)
1. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.
Barnett GC; Thompson D; Fachal L; Kerns S; Talbot C; Elliott RM; Dorling L; Coles CE; Dearnaley DP; Rosenstein BS; Vega A; Symonds P; Yarnold J; Baynes C; Michailidou K; Dennis J; Tyrer JP; Wilkinson JS; Gómez-Caamaño A; Tanteles GA; Platte R; Mayes R; Conroy D; Maranian M; Luccarini C; Gulliford SL; Sydes MR; Hall E; Haviland J; Misra V; Titley J; Bentzen SM; Pharoah PD; Burnet NG; Dunning AM; West CM
Radiother Oncol; 2014 May; 111(2):178-85. PubMed ID: 24785509
[TBL] [Abstract][Full Text] [Related]
2. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Barnett GC; Coles CE; Elliott RM; Baynes C; Luccarini C; Conroy D; Wilkinson JS; Tyrer J; Misra V; Platte R; Gulliford SL; Sydes MR; Hall E; Bentzen SM; Dearnaley DP; Burnet NG; Pharoah PD; Dunning AM; West CM
Lancet Oncol; 2012 Jan; 13(1):65-77. PubMed ID: 22169268
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Jandu HK; Veal CD; Fachal L; Luccarini C; Aguado-Barrera ME; Altabas M; Azria D; Baten A; Bourgier C; Bultijnck R; Colciago RR; Farcy-Jacquet MP; Chang-Claude J; Choudhury A; Dunning A; Elliott RM; Green S; Gutiérrez-Enríquez S; Herskind C; Lambrecht M; Monten C; Rancati T; Reyes V; Rosenstein BS; De Ruysscher D; Carmen De Santis M; Seibold P; Sperk E; Veldwijk M; Paul Symonds R; Stobart H; Taboada-Valladares B; Vega A; Veldeman L; Webb AJ; Weltens C; West CM; Rattay T; Talbot CJ;
Radiother Oncol; 2023 Oct; 187():109806. PubMed ID: 37437607
[TBL] [Abstract][Full Text] [Related]
4. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
5. No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study.
Barnett GC; Coles CE; Burnet NG; Pharoah PD; Wilkinson J; West CM; Elliott RM; Baynes C; Dunning AM
Radiother Oncol; 2010 Oct; 97(1):9-14. PubMed ID: 20096948
[TBL] [Abstract][Full Text] [Related]
6. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity.
Ahmed M; Dorling L; Kerns S; Fachal L; Elliott R; Partliament M; Rosenstein BS; Vega A; Gómez-Caamaño A; Barnett G; Dearnaley DP; Hall E; Sydes M; Burnet N; Pharoah PD; Eeles R; West CM
Br J Cancer; 2016 May; 114(10):1165-74. PubMed ID: 27070714
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
[TBL] [Abstract][Full Text] [Related]
10. Radiogenomics: associations in all the wrong places?
Parliament MB
Lancet Oncol; 2012 Jan; 13(1):7-8. PubMed ID: 22169270
[No Abstract] [Full Text] [Related]
11. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
Seibold P; Behrens S; Schmezer P; Helmbold I; Barnett G; Coles C; Yarnold J; Talbot CJ; Imai T; Azria D; Koch CA; Dunning AM; Burnet N; Bliss JM; Symonds RP; Rattay T; Suga T; Kerns SL; Bourgier C; Vallis KA; Sautter-Bihl ML; Claßen J; Debus J; Schnabel T; Rosenstein BS; Wenz F; West CM; Popanda O; Chang-Claude J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1084-1092. PubMed ID: 26072091
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity.
Fachal L; Mosquera-Miguel A; Gómez-Caamaño A; Sánchez-García M; Calvo P; Lobato-Busto R; Salas A; Vega A
Radiother Oncol; 2014 May; 111(2):199-205. PubMed ID: 24746576
[TBL] [Abstract][Full Text] [Related]
14. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.
Barnett GC; Elliott RM; Alsner J; Andreassen CN; Abdelhay O; Burnet NG; Chang-Claude J; Coles CE; Gutiérrez-Enríquez S; Fuentes-Raspall MJ; Alonso-Muñoz MC; Kerns S; Raabe A; Symonds RP; Seibold P; Talbot CJ; Wenz F; Wilkinson J; Yarnold J; Dunning AM; Rosenstein BS; West CM; Bentzen SM
Radiother Oncol; 2012 Dec; 105(3):289-95. PubMed ID: 23199655
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.
Lee E; Takita C; Wright JL; Slifer SH; Martin ER; Urbanic JJ; Langefeld CD; Lesser GJ; Shaw EG; Hu JJ
Hum Genomics; 2019 Jun; 13(1):28. PubMed ID: 31196165
[TBL] [Abstract][Full Text] [Related]
16. Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.
Dorling L; Barnett GC; Michailidou K; Coles CE; Burnet NG; Yarnold J; Elliott RM; Dunning AM; Pharoah PD; West CM
Clin Cancer Res; 2016 Mar; 22(6):1413-20. PubMed ID: 26510858
[TBL] [Abstract][Full Text] [Related]
17. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.
Fachal L; Gómez-Caamaño A; Barnett GC; Peleteiro P; Carballo AM; Calvo-Crespo P; Kerns SL; Sánchez-García M; Lobato-Busto R; Dorling L; Elliott RM; Dearnaley DP; Sydes MR; Hall E; Burnet NG; Carracedo Á; Rosenstein BS; West CM; Dunning AM; Vega A
Nat Genet; 2014 Aug; 46(8):891-4. PubMed ID: 24974847
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
[TBL] [Abstract][Full Text] [Related]
19. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.
Kerns SL; Stone NN; Stock RG; Rath L; Ostrer H; Rosenstein BS
J Urol; 2013 Jul; 190(1):102-8. PubMed ID: 23376709
[TBL] [Abstract][Full Text] [Related]
20. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Grossberg AJ; Lei X; Xu T; Shaitelman SF; Hoffman KE; Bloom ES; Stauder MC; Tereffe W; Schlembach PJ; Woodward WA; Buchholz TA; Smith BD
JAMA Oncol; 2018 Dec; 4(12):1751-1757. PubMed ID: 30027292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
